News | Artificial Intelligence | August 11, 2020

Automated imaging analysis technology can help clinicians provide faster, accurate diagnoses

Building on its commitment to providing customers with artificial intelligence (AI) solutions that can be utilized across modalities in routine care, Canon Medical Systems USA, Inc. is partnering with Zebra Medical Vision to offer its AI1 automated imaging analysis solutions to help clinicians in the U.S. provide faster, accurate diagnoses for optimized patient care

August 11, 2020 — Building on its commitment to providing customers with artificial intelligence (AI) solutions that can be utilized across modalities in routine care, Canon Medical Systems USA, Inc. is partnering with Zebra Medical Vision to offer its AI1 automated imaging analysis solutions to help clinicians in the U.S. provide faster, accurate diagnoses for optimized patient care. 

Zebra Medical’s AI1 technology provides cloud-based analysis of images through FDA-cleared AI solutions, trained on hundreds of millions of patient scans to triage acute medical conditions, detect incidental findings and stratify risk. This partnership with Canon Medical Systems USA, Inc. marks the introduction of Zebra Medical’s solution into the modality space, bringing AI analysis closer to the point of care.

“We are excited about the partnership with Canon Medical Systems USA, Inc., a company taking innovative and proactive steps to ensure AI adoption for better patient care. The integration of our solution into the modality space allows us to realize Zebra Medical’s vision of improving patient care at scale. Thanks to the strong product integration between the two companies, Canon Medical customers can save crucial time reaching acute cases faster, and enjoy AI insights directly in their workflow seamlessly,” said Ohad Arazi, CEO of Zebra Medical Vision.

“By partnering with Zebra Medical, Canon Medical Systems USA, Inc. is further proving our leadership and commitment to innovation in diagnostic imaging through accessible AI,” said Satrajit Misra, senior vice president, Marketing and Strategic Development, and acting vice president, Sales, Canon Medical Systems USA, Inc. “As we continue to expand our AI offerings across systems and modalities, we’re elevating the diagnostic imaging capabilities for our customers and providing more opportunities to improve patient care than ever before.”

For more information: www.zebra-med.com


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now